Oral nano‐curcumin formulation efficacy in the management of mild to moderate outpatient COVID‐19: A randomized triple‐blind placebo‐controlled clinical trial-Reference-Cited by-同舟云学术

Oral nano‐curcumin formulation efficacy in the management of mild to moderate outpatient COVID‐19: A randomized triple‐blind placebo‐controlled clinical trial

Published:2021-06-19 Issue:8 Volume:9 Page:4068-4075
ISSN:2048-7177
Container-title:Food Science & Nutrition
language:en
Short-container-title:Food Sci. Nutr.

Author:

Ahmadi Reza¹,Salari Soofia²,Sharifi Mohammad Davood³⁴,Reihani Hamidreza³⁴,Rostamiani Mohammad Bagher²,Behmadi Morteza³⁴,Taherzadeh Zhila⁵,Eslami Saeed⁶,Rezayat Seyed Mahdi⁷,Jaafari Mahmoud Reza⁸⁹,Elyasi Sepideh¹^ORCID

Affiliation:

1. Department of Family Medicine School of Medicine Mashhad University of Medical Sciences Mashhad Iran

2. Department of Clinical Pharmacy School of Pharmacy Mashhad University of Medical Sciences Mashhad Iran

3. Faculty of Medicine Department of Emergency Medicine Mashhad University of Medical sciences Mashhad Iran

4. Department of Internal Medicine Mashhad University of Medical Sciences Mashhad Iran

5. Targeted Drug Delivery Research Center School of Pharmacy Mashhad University of Medical Sciences Mashhad Iran

6. Faculty of Medicine Department of Medical Informatics Mashhad University of Medical Sciences Mashhad Iran

7. Department of Pharmacology School of Medicine Tehran University of Medical Sciences Tehran Iran

8. Nanotechnology Research Center Pharmaceutical Technology Institute Mashhad University of Medical Sciences Mashhad Iran

9. Department of Pharmaceutical Nanotechnology School of Pharmacy Mashhad University of Medical Sciences Mashhad Iran

Funder

Mashhad University of Medical Sciences

Publisher

Wiley

Subject

Food Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/fsn3.2226

Reference31 articles.

1. Safety and Efficacy of Nanocurcumin as Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial

2. Curcumin as a potential treatment for COVID‐19;Airton Castro Rocha F. A.;Phytotherapy Research,2020

3. Curcumin as a preventive or therapeutic measure for chemotherapy and radiotherapy induced adverse reaction: A comprehensive review

4. Curcumin and muscle wasting—A new role for an old drug?

5. Bradykinin sensitizes the cough reflex via a B2 receptor dependent activation of TRPV1 and TRPA1 channels through metabolites of cyclooxygenase and 12-lipoxygenase

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunoregulatory effects of nanocurcumin in inflammatory milieu: Focus on COVID-19;Biomedicine & Pharmacotherapy;2024-02

2. Nanocurcumin supplementation improves pulmonary function in severe COPD patients: A randomized, double blind, and placebo‐controlled clinical trial;Phytotherapy Research;2024-01-04

3. Effects of Iranian herbal Zofa? syrup for the management of clinical symptoms in patients with COVID-19: A randomized clinical trial;AVICENNA J PHYTOMEDI;2023

4. Review: The Chemistry, Toxicity and Antibacterial Activity of Curcumin and Its Analogues;Planta Medica;2023-08-21

5. Adjunctive nano‐curcumin therapy improves inflammatory and clinical indices in children with cystic fibrosis: A randomized clinical trial;Food Science & Nutrition;2023-03-28